This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.

This CTD dossier owner and manufacturer has been operating for over three decades, focusing on innovative products in the fields of women's health, gynecology, dermatology, and oncology. Their expertise lies in developing novel products using a proprietary technology that leverages natural extraction methods, particularly plant stem cells. This method enhances the delivery and effectiveness of bioactive compounds, leading to improved efficacy in various skin applications, particularly women's health conditions. They manufacture a range of prescription and over-the-counter products, primarily in the form of solids, liquids, and injectables. The company has received EU and USA GMP approvals for its production lines, demonstrating its commitment to quality and safety standards. While specific product patents are not readily available, their commitment to research and innovation suggests a robust patent portfolio.

Established in 2011, this Danish-based MedTech manufacturer specializes in developing, manufacturing, and commercializing innovative substance-based medical devices and cosmetics containing bioactive cannabidiol (CBD) derived from the Cannabis sativa L. plant. As a CTD dossier owner and manufacturer, it holds GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Europe, the United States, India, Australia, and Israel.